ENDRA Life Sciences Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by ENDRA Life Sciences Inc. on June 8, 2021. The report details the certified results of the Company's 2021 Annual Meeting of Stockholders held on the same date. The Company is incorporated in Delaware and is classified as an emerging growth company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results rather than financial performance data.
Material Changes
No material financial changes or operational updates are reported in this filing. The document serves to disclose the outcome of stockholder votes regarding board composition and auditor ratification.
Guidance, Outlook, and Management Commentary
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It strictly reports the vote tallies for two proposals submitted to security holders.
Investor Verification Checklist
- Verify the election results for the five nominated directors: Francois Michelon, Louis J. Basenese, Anthony DiGiandomenico, Michael Harsh, and Alexander Tokman.
- Confirm the ratification of RBSM LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2021.
- Review the Proxy Statement filed on April 29, 2021, for detailed background on the proposals and director biographies.
- Note that there were no broker non-votes recorded for either proposal.